Skip to content

Remimazolam combined with remifentanil for moderate sedation in awake fiberoptic intubation

Remimazolam combined with remifentanil for moderate sedation in awake fiberoptic intubation

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042917
Enrollment
Unknown
Registered
2021-01-31
Start date
2021-02-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway management

Interventions

Remifentanil alone:Infusion of remifentanil
Remifentanil combined with remimazolam 0.2:Combined infusion of remifentanil and remimazolam
Remifentanil combined with remimazolam 0.4:Combined infusion of remifentanil and remimazolam
Remifentanil combined with remimazolam 0.6:Combined infusion of remifentanil and remimazolam
Remimazolam alone:Infusion of remimazolam

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective surgery under general anesthesia with endotracheal intubation,aged 18-60 years old, ASA 1-2, and predicted operation time >= 2 h.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women, BMI >= 30, severe cardiopulmonary disease, bradycardia, hypotension, a history of drug and/or alcohol abuse, allergy to study drugs;incooperative patients with mental retardation or mental disorders and refusal to participate in the study.

Design outcomes

Primary

MeasureTime frame
Bispectral index;Modified Observers' Assessment of Alertness/Sedation scale;Reaction to placement of the fiberoptic scope and endotracheal tube;Cough severity;Tolerance to the endotracheal tube in the trachea;Intubation time;Lidocaine requirements;Recall of the procedure;Willingness to accept the procedure again;

Secondary

MeasureTime frame
Blood pressure;Heart rate;Pulse oximetry;Complications such as deep sedation and respiratory depression;The first partial pressure of end-tidal CO2 after intubation;

Countries

China

Contacts

Public ContactChengwen Li

Beijing Friendship Hospital, Capital Medical University

lichwen2008@126.com+86 10 6316 8761

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026